Association study between nonsense polymorphism (rs2039381, Gln71Stop) of Interferon-ε and susceptibility to vitiligo in Korean population

Immunological Investigations

Volumn 42, Issue 5, 2013, Pages 423-430

  Cho, Hee Ryung ^a   Kim, Su Kang ^a   Lim, Hee Kyeong ^a   Jeong Park, Hae ^a   Chung, Joo Ho ^a   Lee, Mu Hyoung ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Interferon epsilon; Nonsense polymorphism; NSV; Type I interferon

Indexed keywords

EPSILON INTERFERON; INTERFERON; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA; VITILIGO;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; CHILD; CODON, NONSENSE; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERFERONS; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VITILIGO; YOUNG ADULT;

EID: 84879521732     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2013.804836     Document Type: Article

References (27)

1. Alzolibani A. (2009). Genetic epidemiology and heritability of vitiligo in the Qassim region of Saudi Arabia. Acta Dermatovenerol Alp Panonica Adriat, 18(3), 119-25
2. D'Osualdo A, Reed JC. (2012). NLRP1, a regulator of innate immunity associated with vitiligo. Pigment Cell Melanoma Res, 25, 5-8
3. Dellánna ML, Picardo M. (2006). A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res, 19(5), 406-11 (Pubitemid 44326402)
4. Dong C, Zafrullah M, Mixson-Hayden T, et al. (2011). Suppression of interferon-Alpha signaling by hepatitis E virus. Hepatology 55(5), 1324-32
5. Ezzedine K, Diallo A, Leaute-Labreze C, et al. (2012). Pre-vs. post-pubertal onset of vitiligo: Multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo. Br J Dermatol, 167(3), 490-5
6. Gauthier Y, Cario Andre M, Taieb A. (2003). A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res, 16(4), 322-32 (Pubitemid 36950564)
7. Hamadah I, Binamer Y, Sanai FM, et al. (2010). Interferon-induced vitiligo in hepatitis C patients: A case series. Int J Dermatol, 49(7), 829-33
8. Hardy MP, Owczarek CM, Jermiin LS, et al. (2004). Characterization of the type I interferon locus and identification of novel genes. Genomics, 84(2), 331-45 (Pubitemid 38834171)
9. Hawn TR, Wu H, Grossman JM, et al. (2005). A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus. Proc Natl Acad Sci USA, 102(30), 10593-7 (Pubitemid 41061599)
10. Hughes GC. (2011). Progesterone and autoimmune disease. Autoimmun Rev 11(6-7), A502-14
11. Bolognia JL, Jorrizzo JL, Rapini RP, et al. (2003). Vitiligo and other disorders of hypopigmentation. Dermatology. Edinburg: Mosby, 947-73
12. Kemp EH, Waterman EA, Weetman AP. (2001). Autoimmune aspects of vitiligo. Autoimmunity, 34(1), 65-77 (Pubitemid 32888276)
13. Lee AY. (2012). Role of keratinocytes in the development of vitiligo. Ann Dermatol, 24(2), 115-25
14. Lu J, Yi L., Zhao J., et al (2012). Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol 86(7);3767-76
15. Matsumiya T, Prescott SM, Stafforini DM. (2007). IFN-epsilon mediates TNF-Alphainduced STAT1 phosphorylation and induction of retinoic acid-inducible gene-I in human cervical cancer cells. J Immunol, 179(7), 4542-9
16. McCombe PA, Greer JM, Mackay IR. (2009). Sexual dimorphism in autoimmune disease. Curr Mol Med 9(9), 1058-79
17. Melton PE, Rutherford S, Voruganti VS, et al. (2010). Bivariate genetic association of KIAA1797 with heart rate in American Indians: The Strong Heart Family Study. Hum Mol Genet, 19(18), 3662-71
18. Nouri K, Busso M, Machler BC. (1997). Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C. Cutis, 60(6), 289-90 (Pubitemid 127469616)
19. Peng FW, Duan ZJ, Zheng LS, et al. (2007). Purification of recombinant human interferon-epsilon and oligonucleotide microarray analysis of interferon-epsilonregulated genes. Protein Expr Purif, 53(2), 356-62
20. Pestka S, Krause CD, Walter MR. (2004). Interferons, interferon-like cytokines, and their receptors. Immunol Rev, 202, 8-32 (Pubitemid 39576902)
21. Seckin D, Durusoy C, Sahin S. (2004). Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection. Pediatr Dermatol, 21(5), 577-9 (Pubitemid 39363180)
22. Shajil EM, Chatterjee S, Agrawal D, et al. (2006). Vitiligo: Pathomechanisms and genetic polymorphism of susceptible genes. Ind J Exp Biol, 44(7), 526-39 (Pubitemid 44049404)
23. Spritz RA. (2011). Recent progress in the genetics of generalized vitiligo. J Genet Genom, 38(7), 271-8 (Pubitemid 47057312)
24. Spritz RA. (2012). Six decades of vitiligo genetics: Genome-wide studies provide insights into autoimmune pathogenesis. J Invest Dermatol, 132(2), 268-73
25. Wang CQ, Cruz-Inigo AE, Fuentes-Duculan J, et al. (2011). Th17 cells and activated dendritic cells are increased in vitiligo lesions. PLoS One, 6(4), e18907
26. Xi Y, Day SL, Jackson RJ, Ranasinghe C. (2012). Role of novel type I interferon epsilon in viral infection and mucosal immunity. Mucosal Immunol, 5(6): 610-622
27. Zhang X. (2012). Genome-wide association study of skin complex diseases. J Dermatol Sci, 66(2), 89-97